March 30, 2018 / 2:11 PM / 4 months ago

BRIEF-Nanobiotix FY Net Loss Widens to ‍​26.1 Million Euros

March 30 (Reuters) - NANOBIOTIX SA:

* TOTAL REVENUE IN 2017 AMOUNTS TO EUR 3.7M VERSUS. EUR 5.4M IN 2016

* CASH AVAILABLE AT DECEMBER 31, 2017 AMOUNTS TO EUR 47.2M.

* FY NET LOSS EUR ‍​26.1 MILLION VERSUS LOSS OF EUR 21.9 MILLION YEAR AGO

* 2018 SHOULD BE ANOTHER YEAR OF GROWTH

* FY CORE OPERATING LOSS EUR 24.9 MILLION VERSUS LOSS OF EUR 21.9 MILLION YEAR AGO

* EXPECTS TO PRESENT RESULTS OF ITS PHASE II/III TRIAL OF NBTXR3 IN SOFT TISSUE SARCOMA IN Q2 2018. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below